Binding_NN
characteristics_NNS
of_IN
the_DT
glucocorticoid_NN
receptor_NN
in_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
in_IN
multiple_JJ
sclerosis_NN
._.

Although_IN
the_DT
exact_JJ
etiology_NN
of_IN
multiple_JJ
sclerosis_NN
-LRB-_-LRB-
MS_NN
-RRB-_-RRB-
remains_VBZ
unresolved_JJ
,_,
immune_JJ
reactions_NNS
are_VBP
believed_VBN
to_TO
be_VB
the_DT
central_JJ
pathogenic_JJ
mechanisms_NNS
._.

Endogenous_JJ
and_CC
therapeutic_JJ
steroid_NN
hormones_NNS
affect_VBP
the_DT
immune_JJ
system_NN
,_,
and_CC
inflammatory_JJ
diseases_NNS
are_VBP
associated_VBN
with_IN
activation_NN
of_IN
the_DT
hypothalamic-pituitary-adrenal_JJ
axis_NN
,_,
providing_VBG
evidence_NN
of_IN
an_DT
immune-endocrine_JJ
interplay_NN
._.

Function_NN
tests_NNS
in_IN
MS_NN
have_VBP
revealed_VBN
dysregulation_NN
of_IN
the_DT
hypothalamic-pituitary-adrenal_JJ
system_NN
in_IN
a_DT
substantial_JJ
proportion_NN
of_IN
patients_NNS
._.

We_PRP
characterized_VBD
glucocorticoid_NN
receptor_NN
-LRB-_-LRB-
GR_NN
-RRB-_-RRB-
binding_NN
in_IN
peripheral_JJ
blood_NN
lymphocytes_NNS
from_IN
39_CD
MS_NN
patients_NNS
and_CC
14_CD
age_NN
-_:
and_CC
sex-matched_JJ
controls_NNS
with_IN
respect_NN
to_TO
dissociation_NN
constant_NN
and_CC
binding_NN
capacity_NN
,_,
using_VBG
a_DT
whole-cell_JJ
binding_VBG
assay_NN
with_IN
-LCB-_-LRB-
3H-RCB-dexamethasone_NN
as_IN
the_DT
ligand_NN
._.

GR_NN
binding_NN
parameters_NNS
did_VBD
not_RB
differ_VB
significantly_RB
between_IN
patients_NNS
-LRB-_-LRB-
Kd_NN
8.98_CD
+_CC
\/_NN
-_:
1.07_CD
nM_NN
,_,
Bmax_NN
183_CD
+_CC
\/_NN
-_:
29.8_CD
fmol\/mg_NN
-RRB-_-RRB-
and_CC
controls_NNS
-LRB-_-LRB-
Kd_NN
9.36_CD
+_CC
\/_NN
-_:
1.17_CD
nM_NN
,_,
Bmax_NN
158_CD
+_CC
\/_NN
-_:
16_CD
fmol\/mg_NN
-RRB-_-RRB-
._.

No_DT
effect_NN
of_IN
age_NN
,_,
sex_NN
,_,
course_NN
,_,
duration_NN
or_CC
severity_NN
of_IN
disease_NN
,_,
or_CC
prior_JJ
steroid_NN
treatments_NNS
was_VBD
detected_VBN
._.

GR_NN
binding_NN
parameters_NNS
were_VBD
analyzed_VBN
in_IN
relation_NN
to_TO
the_DT
results_NNS
of_IN
the_DT
combined_JJ
dexamethasone-CRH_JJ
test_NN
,_,
which_WDT
reflects_VBZ
corticosteroid_NN
receptor_NN
function_NN
at_IN
the_DT
hypothalamus_NN
,_,
in_IN
30_CD
patients_NNS
and_CC
9_CD
controls_NNS
._.

While_IN
controls_NNS
showed_VBD
a_DT
moderate_JJ
correlation_NN
between_IN
binding_NN
affinity_NN
of_IN
the_DT
GR_NN
in_IN
lymphocytes_NNS
and_CC
regulatory_JJ
function_NN
at_IN
the_DT
hypothalamic_JJ
level_NN
,_,
the_DT
patients_NNS
did_VBD
not_RB
._.

These_DT
data_NNS
suggest_VBP
that_IN
the_DT
physiological_JJ
relationship_NN
between_IN
binding_NN
and_CC
function_NN
of_IN
the_DT
glucocorticoid_NN
receptor_NN
is_VBZ
disturbed_VBN
in_IN
MS_NN
._.

